Organon (NYSE: OGN), a global healthcare company with a mission to improve the health of women throughout their lives, today announced the successful completion of its acquisition of Dermavant Sciences Ltd. from Roivant (NASDAQ: ROIV). Dermavant is a company dedicated to developing and
therapy
Researchers explore accelerated version of TMS A groundbreaking therapy that utilises magnetic fields on both sides of the brain has demonstrated effectiveness in swiftly alleviating depression symptoms, particularly for patients who have not responded to traditional treatments. This innovative method, repetitive transcranial magnetic stimulation (TMS), can be administered